Intelligent Bio Solutions announced the successful exhibition of its Intelligent Fingerprinting Drug Screening Solution at The Health & Safety Event 2024, the United Kingdom’s largest annual technology showcase exhibiting products and services that strengthen and support workplace safety standards. Harry Simeonidis, President & CEO at Intelligent Bio Solutions, added, “Our success at the 2024 Health & Safety Event reaffirms that our fingerprint drug screening technology is well suited to meet the evolving safety needs of industries worldwide. The high level of engaged and enthusiastic feedback we received further fuels our dedication to advancing non-invasive, rapid drug testing solutions. This event has been pivotal in raising the profile of our business and showcasing our drug screening technology. This year has set a new benchmark for our continued success.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INBS:
- Innovative Fingerprint Drug Screening Solution Showcased at the UK’s Premier Health and Safety Event
- Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational Highlights
- Intelligent Bio Solutions reports Q3 EPS ($1.43) vs ($68.67) last year
- Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue Results
- Intelligent Bio Solutions sees Q3 revenue $0.82M, up 80% vs. last year
